| 2026-01-28 |
财报披露：
美东时间 2026-01-28 盘后发布财报
|
| 2025-11-24 |
详情>>
内部人交易：
Russo Carl股份增加10000.00股
|
| 2025-10-30 |
详情>>
股本变动：
变动后总股本6627.65万股
|
| 2025-10-30 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.16美元,归母净利润1067.20万美元,同比去年增长190.26%
|
| 2025-07-22 |
详情>>
业绩披露：
2025年中报每股收益-0.08美元,归母净利润-498.6万美元,同比去年增长36.52%
|
| 2025-04-22 |
详情>>
业绩披露：
2025年一季报每股收益-0.07美元,归母净利润-478.7万美元,同比去年增长-4747.57%
|
| 2025-03-27 |
股东大会：
将于2025-05-08召开股东大会
会议内容 ▼▲
- 1.To elect three directors to the Calix Board of Directors (“Board”);
2.To approve the Fourth Amended and Restated 2019 Equity Incentive Award Plan (as amended and restated, the “2019 Plan”) to increase the number of shares of common stock issuable under the 2019 Plan by 4,000,000 shares;
3.To approve 1,250,000 shares of common stock reserved for issuance for the matching component of the Calix, Inc. Stock Purchase and Matching Plan (the "Stock Purchase and Matching Plan"), which constitutes an amendment and restatement of the Third Amended and Restated 2017 Nonqualified Employee Stock Purchase Plan (the “Nonqualified ESPP”);
4.To approve, on a non-binding, advisory basis, the compensation of our named executive officers (“NEOs”);
5.To ratify the selection of KPMG LLP as Calix’s independent registered public accounting firm for the fiscal year ending December 31, 2025;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-02-21 |
详情>>
业绩披露：
2024年年报每股收益-0.45美元,归母净利润-2974.7万美元,同比去年增长-201.44%
|
| 2025-02-21 |
详情>>
业绩披露：
2022年年报每股收益0.63美元,归母净利润4101.00万美元,同比去年增长-82.8%
|
| 2024-10-29 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.18美元,归母净利润-1182.3万美元,同比去年增长-132.91%
|
| 2024-07-23 |
详情>>
业绩披露：
2024年中报每股收益-0.12美元,归母净利润-785.5万美元,同比去年增长-141.41%
|
| 2024-07-23 |
详情>>
业绩披露：
2023年中报每股收益0.29美元,归母净利润1897.10万美元,同比去年增长21.30%
|
| 2024-04-23 |
详情>>
业绩披露：
2024年一季报每股收益0.00美元,归母净利润10.30万美元,同比去年增长-98.93%
|
| 2024-03-28 |
股东大会：
将于2024-05-09召开股东大会
会议内容 ▼▲
- 1.To elect two directors to the Calix Board of Directors (“Board”).
2.To approve, on a non-binding, advisory basis, the compensation of our named executive officers (“NEOs”).
3.To ratify the selection of KPMG LLP as Calix’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-02-23 |
详情>>
业绩披露：
2023年年报每股收益0.44美元,归母净利润2932.50万美元,同比去年增长-28.49%
|
| 2023-10-24 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.54美元,归母净利润3592.40万美元,同比去年增长23.52%
|
| 2023-03-31 |
股东大会：
将于2023-05-11召开股东大会
会议内容 ▼▲
- 1.To elect two directors to the Calix Board of Directors (“Board”);
2.To approve the Third Amended and Restated 2019 Equity Incentive Award Plan (as amended and restated, the “2019 Plan”) to increase the number of shares of common stock issuable under the 2019 Plan by 1,500,000 shares;
3.To approve the Third Amended and Restated 2017 Nonqualified Employee Stock Purchase Plan (as amended and restated, the “Nonqualified ESPP”) to increase the number of shares of common stock issuable under the Nonqualified ESPP by 1,200,000 shares;
4.To approve, on a non-binding, advisory basis, the compensation of our named executive officers (“NEOs”);
5.To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve the compensation of our NEOs;
6.To ratify the selection of KPMG LLP as Calix’s independent registered public accounting firm for the fiscal year ending December 31, 2023;
7.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-04-01 |
股东大会：
将于2022-05-12召开股东大会
会议内容 ▼▲
- 1.To elect four directors to the Calix Board of Directors (“Board”);
2.To approve the Amended and Restated 2019 Equity Incentive Award Plan (“2019 Plan”) to increase the number of shares of common stock issuable under the 2019 Plan by 1,500,000 shares;
3.To approve the Amended and Restated Employee Stock Purchase Plan (“ESPP”) to increase the number of shares of common stock issuable under the ESPP by 1,300,000 shares;
4.To approve the Amended and Restated 2017 Nonqualified Employee Stock Purchase Plan (“Nonqualified ESPP”) to increase the number of shares of common stock issuable under the Nonqualified ESPP by 800,000 shares;
5.To approve, on a non-binding, advisory basis, the compensation of our named executive officers;
6.To ratify the selection of KPMG LLP as Calix’s independent registered public accounting firm for the fiscal year ending December 31, 2022;
7.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-01 |
股东大会：
将于2021-05-13召开股东大会
会议内容 ▼▲
- 1.To elect three directors to the Calix Board of Directors (“Board”);
2.To approve the Amended and Restated 2019 Equity Incentive Award Plan (“2019 Plan”) to increase the number of shares of common stock issuable under the 2019 Plan by 3,800,000 shares;
3.To approve the Amended and Restated Employee Stock Purchase Plan (“ESPP”) to increase the number of shares of common stock issuable under the ESPP by 1,300,000 shares;
4.To approve the Amended and Restated 2017 Nonqualified Employee Stock Purchase Plan (“Nonqualified ESPP”) to increase the number of shares of common stock issuable under the Nonqualified ESPP by 800,000 shares;
5.To approve, on a non-binding, advisory basis, the compensation of our named executive officers;
6.To ratify the selection of KPMG LLP as Calix’s independent registered public accounting firm for the fiscal year ending December 31, 2021;
7.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-04-01 |
股东大会：
将于2020-05-13召开股东大会
会议内容 ▼▲
- 1.To elect three directors to the Calix Board of Directors (“Board”);
2.To approve the Amended and Restated 2019 Equity Incentive Award Plan (“2019 Plan”) to increase the number of shares of common stock issuable under the 2019 Plan by 3,500,000 shares;
3.To approve the Amended and Restated 2017 Nonqualified Employee Stock Purchase Plan (“Nonqualified ESPP”) to amend certain terms and increase the number of shares of common stock issuable under the Nonqualified ESPP by 1,200,000 shares;
4.To approve, on a non-binding, advisory basis, the compensation of our named executive officers;
5.To ratify the selection of KPMG LLP as Calix’s independent registered public accounting firm for the fiscal year ending December 31, 2020;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2019-04-02 |
股东大会：
将于2019-05-22召开股东大会
会议内容 ▼▲
- 1.To elect four directors to the Calix Board of Directors (“Board”);
2.To approve the 2019 Equity Incentive Award Plan;
3.To approve the Amended and Restated Employee Stock Purchase Plan (“ESPP”) to increase the number of shares of common stock issuable under the ESPP by 2,500,000;
4.To approve, on a non-binding, advisory basis, the compensation of our named executive officers;
5.To ratify the selection of KPMG LLP as Calix’s independent registered public accounting firm for the fiscal year ending December 31, 2019;
6.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2018-04-03 |
股东大会：
将于2018-05-16召开股东大会
会议内容 ▼▲
- 1.To elect four directors to the Calix Board of Directors (“Board”);
2.To approve the Amended and Restated 2017 Nonqualified Employee Stock Purchase Plan (“Nonqualified ESPP”) to amend certain terms and increase the number of shares of common stock issuable under the Nonqualified ESPP by 2,500,000;
3.To approve, on a non-binding, advisory basis, the compensation of our named executive officers;
4.To ratify the selection of KPMG LLP as Calix’s independent registered public accounting firm for the fiscal year ending December 31, 2018; 5.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2017-04-04 |
股东大会：
将于2017-05-17召开股东大会
会议内容 ▼▲
- 1.To elect two directors to the Calix Board of Directors (“Board”);
2.To approve the Amended and Restated Employee Stock Purchase Plan (“ESPP”) to increase the number of shares of common stock issuable under the ESPP by 3,000,000;
3.To approve the 2017 Nonqualified Employee Stock Purchase Plan;
4.To approve, on a non-binding, advisory basis, the compensation of our named executive officers (“NEOs”);
5.To approve, on a non-binding, advisory basis, the frequency of future advisory votes to approve the compensation of our NEOs;
6.To ratify the selection of KPMG LLP as Calix’s independent registered public accounting firm for the fiscal year ending December 31, 2017;
7.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2016-04-05 |
股东大会：
将于2016-05-18召开股东大会
会议内容 ▼▲
- 1.To elect two directors to the Calix Board of Directors (“Board”);
2.To approve, on a non-binding, advisory basis, the compensation of our named executive officers (“NEOs”);
3.To ratify the selection of KPMG LLP as Calix’s independent registered public accounting firm for the fiscal year ending December 31, 2016;
4.To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2013-10-30 |
复牌提示：
2013-10-30 09:32:41 停牌，复牌日期 2013-10-30 09:36:58
|